Massive Levemir (Long-Acting) Insulin Overdose: Case Report

Abstract

A 52-year-old insulin-dependant diabetic man presented to the Emergency Department 2 hours after a deliberate massive overdose of 2100 units of long-acting Levemir insulin and a large quantity of whisky. On initial assessment, his GCS was 3/15 and his capillary blood sugar was 2.6 mmol/L. The patient was given a 50 ml bolus of 50% dextrose, followed by intravenous infusions of both 5% and 10% dextrose. Despite the continuous infusions, he experienced 4 symptomatic hypoglycaemic episodes in the first 12 hours after admission. These were managed with oral glucose, IM glucagon, and further dextrose boluses. Blood electrolytes and pH were monitored throughout. Insulin overdoses are relatively common and often occur with an excess of other drugs or alcohol which can enhance its action. Overdoses can result in persistent hypoglycaemia, liver enzyme derangement, electrolyte abnormalities, and neurological damage. Overall mortality is 2.7% with prognosis poorest in patients who are admitted with decreased Glasgow Coma scale (GCS) 12 hours after overdose.

Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus

“…As high blood glucose levels are one of the leading causes of cardiomyopathy, an efficient blood glucose control strategy is crucial for effective cardioprotection. Currently, insulin injection is a routinely practised clinical prescription, but insulin shock is a serious side effect that has to be considered before it is prescribed ( 6 ) .…”

Inadvertent iatrogenic insulin detemir 1000 units overdose in a hospitalised patient

“…There are several reported cases of intentional large insulin overdoses mainly with suicidal attempts. Few reported cases were glargine 3800 units,2 detemir 2100 units3 and NPH 2500 units 4. One of the review studies in 2018 mentioned median insulin overdose of 900 units with the range 26–4800 units 5.…”

Prolonged Severe Hypoglycemia in a Pediatric Patient With Type 1 Diabetes

“…Case reports and pharmacodynamics studies have demonstrated that the pharmacokinetics of all insulins change depending on the dose administered. This is especially true for the long-acting insulin analogs, which have been shown to have an effect up to four times their normal duration (3,5,7–14). The reason for this prolonged effect is postulated to be the result of delayed absorption of a large dose of insulin, or the “depot effect,” and/or slower dose-dependent absorption of subcutaneous depot injections (11,15–18).…”